Results 151 to 160 of about 186,524 (347)

A phenomap of TTR amyloidosis to aid diagnostic screening

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos   +4 more
wiley   +1 more source

Electrical Pacing of the Heart with Endocardial and Implanted Pacemakers

open access: green, 1966
KARL E. KAHLSON   +3 more
openalex   +2 more sources

Treatment of Congenital and Acquired Heart Block with an Implantable Pacemaker [PDF]

open access: bronze, 1964
Rodman E. Taber   +3 more
openalex   +1 more source

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García   +17 more
wiley   +1 more source

Cardiac magnetic resonance in a patient with MRI-conditional pacemaker

open access: yesRevista Portuguesa de Cardiologia, 2013
An implanted pacemaker is generally considered a contraindication for magnetic resonance imaging (MRI). The increasing number of indications for MRI and the rising prevalence of implanted cardiac pacemakers have prompted the recent development of MRI ...
António Miguel Ferreira   +4 more
doaj  

Mop3 Is an Essential Component of the Master Circadian Pacemaker in Mammals

open access: yesCell, 2000
M. Bunger   +8 more
semanticscholar   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

The use of echocardiography and echocardiographic findings in patients hospitalized for acute heart failure

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Transthoracic echocardiography (TTE) is recommended as a key investigation in patients with acute heart failure (AHF) in major guidelines. However, utilization and benefits are yet to be known in Thai patients. The study aims to evaluate the benefits of TTE and identify factors associated with the decision to perform TTE on patients with ...
Koravich Lorlowhakarn   +9 more
wiley   +1 more source

Pacemaker implantation complication rates in elderly and young patients

open access: yesClinical Interventions in Aging, 2013
Kazim Serhan Özcan, Damirbek Osmonov, Servet Altay, Cevdet Dönmez, Ersin Yildirim, Ceyhan Türkkan, Baris Güngör, Ahmet Ekmekçi, Ahmet Taha Alper, Kadir Gürkan, İzzet ErdinlerDepartment of Cardiology, Siyami Ersek ...
Özcan KS   +10 more
doaj  

Home - About - Disclaimer - Privacy